TRIM63 as a biomarker for MiT family RCC

from Springer Nature · host Springer Nature

In this episode Dr. Rohit Mehra of University of Michigan discusses the utility of TRIM63 as a diagnostic marker to distinguish MiTF-RCC from other renal tumor subtypes with overlapping morphology. In combination with TFE3/TFEB FISH, TRIM63 RNA-ISH assays can improve the accuracy and efficiency of MiTF-RCC diagnosis. Associated article: TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. https://www.nature.com/articles/s41379-021-00803-z

Episode metadata supplied by the publisher feed · Published Aug 12, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

TRIM63 as a biomarker for MiT family RCC

0:00 20:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Springer Nature?

This episode is 20 minutes long.

When was this Springer Nature episode published?

This episode was published on August 12, 2021.

Can I download this Springer Nature episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!